Universität zu Köln

Journal Article

Ettrich, T., Perkofer, L., Berger, A. W., Guethle, M., Behl, S., Zipprich, A., Woerns, M. A., Waldschmidt, D. T., Belle, S., Michl, P., Seufferlein, T. and Dollinger, M. M. (2015). Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIb trial. Eur. J. Cancer, 51. S. S457 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852